Athira Pharma, Inc. (ATHA)
NASDAQ: ATHA · Real-Time Price · USD
0.642
-0.007 (-1.00%)
At close: Nov 20, 2024, 4:00 PM
0.687
+0.045 (6.96%)
Pre-market: Nov 21, 2024, 4:41 AM EST
Athira Pharma Market Cap
Athira Pharma has a market cap or net worth of $24.69 million as of November 21, 2024. Its market cap has decreased by -58.14% in one year.
Market Cap
24.69M
Enterprise Value
-42.85M
1-Year Change
-58.14%
Ranking
Category
Stock Price
$0.64
Market Cap Chart
Since the IPO on September 18, 2020, Athira Pharma's market cap has decreased from $489.85M to $24.69M, a decrease of -94.96%. That is a compound annual growth rate of -51.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 24.94M | -73.03% |
| Dec 29, 2023 | 92.47M | -22.89% |
| Dec 30, 2022 | 119.92M | -75.36% |
| Dec 31, 2021 | 486.68M | -56.26% |
| Dec 31, 2020 | 1.11B | 127.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Longeveron | 25.99M |
| RenovoRx | 25.67M |
| Lipocine | 25.24M |
| GeoVax Labs | 25.15M |
| DarioHealth | 25.06M |
| Allurion Technologies | 24.62M |
| Pulmatrix | 24.54M |
| Equillium | 24.12M |